Features

Big data thrived during a year of crises

Data has shown itself to be an increasingly valuable asset since covid-19 was declared a global pandemic one year ago, according to the GDR Big Data Index. Privacy laws, antitrust enforcement and other regulations could serve as headwinds in 2021.

22 March 2021

Searching for the exit: data considerations in early-stage investment

The days of ‘move fast and break things’ are long gone. Where fast-growing technology companies once prioritised growth and largely ignored collateral damage – including to data protection and privacy – today’s startups are taking a markedly more cautious approach to data risk.

22 March 2021

UK data protection litigation analysis: who’s getting sued?

GDR litigation data reveals which industries and sectors are bearing the brunt of data protection litigation – and confirms that the number of High Court cases has risen dramatically.

18 March 2021

UK data protection litigation analysis: the lawyers leading the way

Data compiled by GDR shows that a handful of firms are responsible for most recent data protection cases in England and Wales.

09 March 2021

UK data protection litigation analysis: class action uptake remains slow

Data compiled by GDR shows that much-hyped collective actions make up a tiny minority of UK data protection litigation.

08 March 2021

UK adequacy decision: end goal in sight

After years of wrangling over Brexit and the terms of the withdrawal agreement, recent squabbles over the importing of vaccines, shellfish and even ham sandwiches have made the issue of UK-EU equivalence a testy subject. As such, the European Commission’s recent UK adequacy decision is encouraging for the data community, says Kim Roberts of King & Spalding.

05 March 2021

What life sciences businesses need to know about data commercialisation

Data is playing an increasingly important part in life science commercial value creation, presenting new revenue-generating opportunities. A strategy for protecting and exploiting data is now a must for entities involved in healthcare research.

04 March 2021

FTC ripped for blacking out Facebook’s privacy report

The US Federal Trade Commission has been slammed for redacting the majority of a report that would ostensibly shine light on Facebook’s internal data policies and practices, with activists accusing the FTC of failing to live up to “transparency” promises it made when announcing the settlement some 20 months ago.

03 March 2021

UK GDPR: What enforcement takes place below the waterline?

Discussions about the enforcement of the GDPR inevitably focus on fines, but they’re only part of the UK data regulator’s toolbox. Linklaters counsel Greg Palmer analyses exclusive data about how the Information Commissioner’s Office uses its powers – and how the UK GDPR enforcement works under the waterline.

01 March 2021

Companies focus on data-led product development, GDR report shows

An exclusive GDR survey suggests the private sector is extensively using data assets to create new products and services – and may be shifting its focus away from commercialising personal data by using it to target online adverts.

26 February 2021

Get unlimited access to all Global Data Review content